Clinical Trials Logo

Vestibulodynia clinical trials

View clinical trials related to Vestibulodynia.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03682601 Terminated - Dyspareunia Clinical Trials

Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment

Start date: August 30, 2018
Phase: Phase 2
Study type: Interventional

This study will evaluate the use of topical 5 or 10% sinecatechins, a botanical drug derived from green tea for the alleviation of sexual pain in the area around the vaginal opening (the vulvar vestibule), that is a main source of pain during sexual contact or dyspareunia, in postmenopausal women, with vulvovaginal atrophy. Women may or may not be using estrogens. Half of the women will receive the study drug, 5 or 10% sinecatechins and half will receive placebo. In addition to the reduction or elimination of pain upon penetration, women may also experience increase in lubrication, arousal and intensity of orgasm

NCT ID: NCT02854670 Terminated - Vestibulodynia Clinical Trials

A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia

CAPSIVU
Start date: January 20, 2016
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to assess the pain on contact in provoked vestibulodynia, measured with Visual Analogic Scale at week 0/week 2/week 6/week 12 after applying a patch of capsaicin.

NCT ID: NCT01295268 Terminated - Vulvodynia Clinical Trials

Study of Emu Oil vs. Placebo for Vulvar Pain in Women.

Start date: February 2011
Phase: N/A
Study type: Interventional

The goal of this study is to determine if vulvar (external female genitalia) pain is decreased with emu oil over a similar placebo oil (no active ingredient) by using measurement devices, examinations, and questionnaires. Topical emu oil has not been scientifically studied for this condition yet, but related reports show no significant side effects or potential benefits. A total of 30 women will participate in the study at William Beaumont Hospital, Royal Oak.